Others have shown that the SIRT3-dependent activation of anti-oxidative Foxo3a targets Ras activation and represses the activity of transcription factors such as GATA4 and NFAT involved in the development of cardiac hypertrophy [38]. Here, FOXO3 is linked to cardiac hypertrophy.